Name: PMV Pharmaceuticals, Inc. (PMVP) Financial Statements
Creator: FinSpry

PMV Pharmaceuticals Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

PMV Pharmaceuticals, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	0.00	0.00	0.00	0.00	0.00
Cost of Revenue	1.14	0.00	0.00	0.00	0.00
Gross Profit	-1.14	0.00	0.00	0.00	0.00
Operating Expenses
Research & Development	57.38	55.89	51.99	36.49	23.93
Selling, General & Administrative	26.92	24.25	25.05	21.80	11.01
Operating Expenses	84.30	80.13	77.04	58.29	34.94
Operating Income	-85.45	-80.13	-77.04	-58.29	-34.94
Other Income/Expense
Interest Income	10.66	11.17	3.63	0.45	0.65
Interest Expense	0.00	0.00	0.00	0.00	0.00
Other Income/Expense	10.64	0.00	0.09	-0.02	-0.14
Income
Income Before Tax	-74.81	-68.96	-73.33	-57.82	-34.43
Income Tax Expense	-16.10	0.00	-0.01	0.02	0.01
Net Income	-58.71	-68.96	-73.32	-57.85	-34.44
Net Income - Continuous Operations	-58.71	-68.96	-73.32	-57.85	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-73.67	-78.88	-76.73	-57.99	-34.62
EBIT	-85.46	-80.13	-77.04	-58.29	-34.94
Depreciation & Amortization	1.14	1.26	0.32	0.31	0.32
Earnings Per Share
Basic EPS	-1.00	-1.00	-2.00	-1.00	-2.00
Diluted EPS	-1.00	-1.00	-2.00	-1.00	-2.00
Basic Shares Outstanding	51.58	48.01	45.59	45.14	14.36
Diluted Shares Outstanding	51.58	48.01	45.59	45.14	14.36